68Ga–Prostate-Specific Membrane Antigen PET/CT in Ovarian Tumors: Potential to Differentiate Benign and Malignant Tumors Before Surgery: A Preliminary Report

J Kunikowska, M Bizoń, K Pełka, P Derlatka… - Clinical Nuclear …, 2023 - journals.lww.com
Results In 3 cases (37.5%), the 68 Ga-PSMA-11 PET/CT was positive, whereas histological
examination confirmed 2 serous ovarian cancer cases and 1 ovarian borderline tumor. The …

[HTML][HTML] Metachronous brain tumor in 177Lu-PSMA scan in a patient with metastatic castration resistant prostate cancer mimicking disease progression

E Pirayesh, M Tavakoli - Molecular Imaging and Radionuclide …, 2023 - ncbi.nlm.nih.gov
A 66-year old man known case of metastatic castration resistant prostate cancer underwent
successful 6 cycles treatment with 177Lu-prostate-specific membrane antigen. On the last …

Evaluation of prostate-specific membrane antigen expression in locally advanced or metastatic breast carcinoma with 68Ga-PSMA-11 positron-emission tomography …

RV Parghane, T Suralkar, D Nikam… - Nuclear Medicine …, 2024 - journals.lww.com
Methods This study examined 41 female patients of BC. All underwent 68 Ga-PSMA-11
PET/CT. For qualitative analysis, a visual estimation of PSMA expression was performed as …

[HTML][HTML] PSMA-targeted [18F] DCFPyL PET/CT-avid lesions in a patient with prostate cancer: Clinical decision-making informed by the PSMA-RADS interpretive …

DK Reyes, S Demehri, RA Werner, MG Pomper… - Urology Case …, 2019 - Elsevier
We present the case of a man with oligometastatic prostate cancer who underwent a PSMA-
targeted 18F-DCFPyL PET/CT scan in order to illustrate how the PSMA-RADS grading …

PSA increase after definitive treatment

T Maurer, B Hadaschik, L Budäus, T Steuber… - Der Urologe, 2019 - Springer
Nach definitiver kurativ intendierter Therapie kommt es bei einem Teil der Patienten mit
Prostatakarzinom zu einem biochemischen Rezidiv. In solchen Fällen erfolgt meist anhand …

18F-PSMA-1007 salivary gland dosimetry: comparison between different methods for dose calculation and assessment of inter-and intra-patient variability

D Pistone, S Gnesin, L Auditore, A Italiano… - Physics in Medicine …, 2023 - iopscience.iop.org
Objective. Simplified calculation approaches and geometries are usually adopted for
salivary glands (SGs) dosimetry. Our aims were (i) to compare different dosimetry methods …

The change of 68Ga–Prostate-specific membrane antigen uptake in myeloma after chemotherapy in a patient with multiple myeloma and concurrent prostate cancer

Q Pan, Y Luo, Y Ma, F Li - Clinical Nuclear Medicine, 2020 - journals.lww.com
A bone lesion in the right calcaneus was found in a 76-year-old man with a history of
prostate cancer. 68 Ga-PSMA-11 PET/CT showed multiple PSMA-expressing lytic bone …

[HTML][HTML] Uptake of prostate-specific membrane antigen-targeted 18F-DCFPyL in avascular necrosis of the femoral head

G Torga, Y Yin, MG Pomper, KJ Pienta… - World Journal of …, 2019 - thieme-connect.com
In recent years, the emergence of prostate-specific membrane antigen (PSMA)-targeted
positron-emission tomography (PET) imaging has brought about a paradigm shift in the way …

18F-FDG PET/CT Versus 68Ga-PSMA-11 PET/CT in Evaluation of Distant Metastatic Disease in Recurrent Renal Cell Carcinoma

RV Parghane, S Basu - Journal of Nuclear Medicine Technology, 2023 - Soc Nuclear Med
Prostate-specific membrane antigen (PSMA) expression has been observed in the
neovasculature of various malignancies. We present a case of metastatic renal cell …

Prostate cancer pulmonary metastasis presenting as a ground-glass pulmonary nodule on 68Ga-PSMA-11 PET/CT

DJ Lubin, SB Holden, MB Rettig, RE Reiter… - Clinical Nuclear …, 2019 - journals.lww.com
Abstract 68 Ga–prostate-specific membrane antigen 11 (PSMA) PET/CT imaging accurately
depicts metastatic prostate adenocarcinoma (PCa). Pulmonary metastases of PCa are often …